First Trust NYSE Arca Biotechnology Index Fund
243 hedge funds and large institutions have $559M invested in First Trust NYSE Arca Biotechnology Index Fund in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 60 increasing their positions, 97 reducing their positions, and 28 closing their positions.
5% less funds holding
Funds holding: 257 → 243 (-14)
12.66% less ownership
Funds ownership: 60.21% → 47.55% (-13%)
25% less capital invested
Capital invested by funds: $746M → $559M (-$187M)
36% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 28
38% less repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 97
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
+$11.8M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$5.2M |
| 3 |
TWC
TD Waterhouse Canada
Toronto,
Ontario, Canada
|
+$4.75M |
| 4 |
BFG
Berger Financial Group
Plymouth,
Minnesota
|
+$3.95M |
| 5 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$2.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$143M |
| 2 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$12.3M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$7.56M |
| 4 |
GVAG
Great Valley Advisor Group
Wilmington,
Delaware
|
-$7.06M |
| 5 |
GS
GTS Securities
New York
|
-$6.31M |
FBT Hedge Fund Activity: Q1 2024 in Review
243 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q1 2024, worth a combined $559M — down 25% from $746M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of FBT and 18 opened new positions — a net loss of 10 holders — while 97 trimmed existing stakes and 60 added.
The largest buyer was LPL Financial, adding an estimated $11.8M. The largest seller was Morgan Stanley, cutting an estimated $143M.
- 243 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q1 2024, down from 257 in Q4 2023.
- Funds reported $559M of First Trust NYSE Arca Biotechnology Index Fund stock for Q1 2024, down 25% quarter-over-quarter.
- 18 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q1 2024 and 28 closed out, a net change of -10 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q1 2024 was LPL Financial, an estimated $11.8M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q1 2024 was Morgan Stanley, an estimated $143M sold.
Based on aggregated 13F filings for Q1 2024.